4//SEC Filing
Stone Christopher Lewis 4
Accession 0000882104-20-000007
CIK 0000882104other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 6:36 PM ET
Size
5.2 KB
Accession
0000882104-20-000007
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Common stock
2020-01-08+422,078→ 621,029 total
Footnotes (1)
- [F1]The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance and retention plans covering the participant.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 6:36 PM ET
- Size
- 5.2 KB